Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience
Published in: European Archives of Psychiatry and Clinical Neuroscience 5/2018

01-08-2018 | Original Paper

Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat

Authors: Rainer Wolf, Henrik Dobrowolny, Sven Nullmeier, Bernhard Bogerts, Herbert Schwegler

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 5/2018

Login to get access

Abstract

The role of the thalamus in schizophrenia has increasingly been studied in recent years. Deficits in the ventral thalamus have been described in only few postmortem and neuroimaging studies. We utilised our previously introduced neurodevelopmental animal model, the neonatal excitotoxic lesion of the ventral thalamus of Sprague–Dawley rats (Wolf et al., Pharmacopsychiatry 43:99–109, 22). At postnatal day (PD7), male pubs received bilateral thalamic infusions with ibotenic acid (IBA) or artificial cerebrospinal fluid (control). In adulthood, social interaction of two animals not familiar to each other was studied by a computerised video tracking system. This study displays clear lesion effects on social interaction of adult male rats. The significant reduction of total contact time and the significant increase in distance between the animals in the IBA group compared to controls can be interpreted as social withdrawal modelling a negative symptom of schizophrenia. The significant increase of total distance travelled in the IBA group can be hypothesised as agitation modelling a positive symptom of schizophrenia. Using a triple concept of social interaction, the percentage of no social interaction (Non-SI%) was significantly larger, and inversely, the percentage of passive social interaction (SI-passive%) was significantly smaller in the IBA group when compared to controls. In conclusion, on the background of findings in schizophrenic patients, the effects of neonatal ventral thalamic IBA lesions in adult male rats support the hypothesis of face and construct validity as animal model of schizophrenia.
Literature
1.
Kovelman JA, Scheibel AB (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19:1601–1621PubMed
2.
Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303–326CrossRefPubMed
3.
Bogerts B (1993) Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431–445CrossRefPubMed
4.
Lawrie SM, Abukmeil SS (1998) Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 172:110–120CrossRefPubMed
5.
Nelson MD, Saykin AJ, Flashman LA, Riordan HJ (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55:433–440CrossRefPubMed
6.
Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16–25CrossRefPubMed
7.
Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669CrossRefPubMed
8.
Bloom FE (1993) Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 50:224–227CrossRefPubMed
9.
Waddington JL (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341:531–536CrossRefPubMed
10.
Murray RM (1994) Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br J Psychiatry Suppl 25:6–12
11.
Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67–75CrossRefPubMed
12.
Fiore M, Talamini L, Angelucci F, Koch T, Aloe L, Korf J (1999) Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38:857–869CrossRefPubMed
13.
Schmadel S, Schwabe K, Koch M (2004) Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat. Neuroscience 128:365–374CrossRefPubMed
14.
Sumiyoshi T, Tsunoda M, Uehara T, Tanaka K, Itoh H, Sumiyoshi C, Kurachi M (2004) Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies. Neurosci Lett 364:124–129CrossRefPubMed
15.
Harich S, Koch M, Schwabe K (2008) Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex. Prog Neuropsychopharmacol Biol Psychiatry 32:816–827CrossRefPubMed
16.
Lipska BK, Al-Amin HA, Weinberger DR (1998) Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19:451–464CrossRefPubMed
17.
Schneider M, Koch M (2005) Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment. Neuropsychopharmacology 30:944–957CrossRefPubMed
18.
Daenen EW, Van Der Heyden JA, Kruse CG, Wolterink G, Van Ree JM (2001) Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus. Brain Res 918:153–165CrossRefPubMed
19.
Bouwmeester H, Wolterink G, Van Ree JM (2002) Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol 442:239–249CrossRefPubMed
20.
Daenen EW, Wolterink G, Van Der Heyden JA, Kruse CG, Van Ree JM (2003) Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. Eur Neuropsychopharmacol 13:187–197CrossRefPubMed
21.
Lipska BK, Luu S, Halim ND, Weinberger DR (2003) Behavioral effects of neonatal and adult excitotoxic lesions of the mediodorsal thalamus in the adult rat. Behav Brain Res 141:105–111CrossRefPubMed
22.
Wolf R, Matzke K, Paelchen K, Dobrowolny H, Bogerts B, Schwegler H (2010) Reduction of prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats. Pharmacopsychiatry 43:99–109CrossRefPubMed
23.
Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 122:35–43CrossRef
24.
Sams-Dodd F, Lipska BK, Weinberger DR (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) 132:303–310CrossRef
25.
Jones EG (1997) Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 23:483–501CrossRefPubMed
26.
27.
28.
Heckers S (1997) Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems. Schizophr Bull 23:403–421CrossRefPubMed
29.
Byne W, Hazlett EA, Buchsbaum MS, Kemether E (2009) The thalamus and schizophrenia: current status of research. Acta Neuropathol 117:347–368CrossRefPubMed
30.
Cronenwett WJ, Csernansky J (2010) Thalamic pathology in schizophrenia. Curr Top Behav Neurosci 4:509–528CrossRefPubMed
31.
Konick LC, Friedman L (2001) Meta-analysis of thalamic size in schizophrenia. Biol Psychiatry 49:28–38CrossRefPubMed
32.
Clinton SM, Meador-Woodruff JH (2004) Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr Res 69:237–253CrossRefPubMed
33.
Sim K, Cullen T, Ongur D, Heckers S (2006) Testing models of thalamic dysfunction in schizophrenia using neuroimaging. J Neural Transm 113:907–928CrossRefPubMed
34.
Lisman J (2012) Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr Opin Neurobiol 22:537–544CrossRefPubMed
35.
Pakkenberg B (1990) Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47:1023–1028CrossRefPubMed
36.
Danos P, Baumann B, Bernstein HG, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B (1998) Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons. Psychiatry Res 82:1–10CrossRefPubMed
37.
Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, Purohit DP, Haroutunian V, Jones L (2002) Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 159:59–65CrossRefPubMed
38.
Andreasen NC, Ehrhardt JC, Swayze VW, Alliger RJ, Yuh WT, Cohen G, Ziebell S (1990) Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 47:35–44CrossRefPubMed
39.
Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr (1996) PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 153:191–199CrossRefPubMed
40.
Brickman AM, Buchsbaum MS, Shihabuddin L, Byne W, Newmark RE, Brand J, Ahmed S, Mitelman SA, Hazlett EA (2004) Thalamus size and outcome in schizophrenia. Schizophr Res 71:473–484CrossRefPubMed
41.
Harms MP, Wang L, Mamah D, Barch DM, Thompson PA, Csernansky JG (2007) Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J Neurosci 27:13835–13842CrossRefPubMed
42.
Smith MJ, Wang L, Cronenwett W, Mamah D, Barch DM, Csernansky JG (2011) Thalamic morphology in schizophrenia and schizoaffective disorder. J Psychiatr Res 45:378–385CrossRefPubMed
43.
44.
Andreasen NC, Olsen S (1982) Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 39:789–794CrossRefPubMed
45.
46.
Meyerson BJ, Hoglund AU (1981) Exploratory and socio-sexual behaviour in the male laboratory rat: a methodological approach for the investigation of drug action. Acta Pharmacol Toxicol (Copenh) 48:168–180CrossRef
47.
Guy AP, Gardner CR (1985) Pharmacological characterisation of a modified social interaction model of anxiety in the rat. NeuropsychoBiology 13:194–200CrossRefPubMed
48.
Corbett R, Hartman H, Kerman LL, Woods AT, Strupczewski JT, Helsley GC, Conway PC, Dunn RW (1993) Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol Biochem Behav 45:9–17CrossRefPubMed
49.
File SE, Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35–53CrossRefPubMed
50.
Wolf, Dobrowolny, Bogerts (2002) Search for an animal model of schizophrenia: effects of neonatal temporolimbic lesions on social interaction in adult rats. Pharmacopsychiatry 35:11
51.
Wolf R, Dobrowolny H, Bogerts B (2004) Computergestützte Messung der sozialen Interaktion nach neonataler Ibotensäure-Läsion des temporolimbischen System der Ratte - ein Tiermodell der Schizophrenie? Nervenarzt 75(Suppl 2):S73
52.
Panther P, Nullmeier S, Dobrowolny H, Schwegler H, Wolf R (2012) CPB-K mice a mouse model of schizophrenia? Differences in dopaminergic, serotonergic and behavioral markers compared to BALB/cJ mice. Behav Brain Res 230:215–228CrossRefPubMed
53.
54.
Klir GJ, Yuan B (1995) Fuzzy sets and fuzzy logic: theory and applications. Prentice Hall, New Jersey
55.
Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum, New York
56.
Ellenbroek BA, Cools AR (1990) Animal models with construct validity for schizophrenia. Behav Pharmacol 1:469–490CrossRefPubMed
57.
Lipska BK, Weinberger DR (1995) Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA 92:8906–8910CrossRefPubMed
58.
Ouhaz Z, Ba-M’hamed S, Mitchell AS, Elidrissi A, Bennis M (2015) Behavioral and cognitive changes after early postnatal lesions of the rat mediodorsal thalamus. Behav Brain Res 292:219–232CrossRefPubMedPubMedCentral
59.
Geyer, Moghaddam B (2002) Animal models relevant to schizophrenia disorders. In: Davis KL, Charney DS, Coyle JT, Nemeroff C (eds) Neuropharmacology: the fifth generation of progress. Lippincott Williams and Wilkins, Philadelphia, pp 689–701
60.
61.
Adriano F, Spoletini I, Caltagirone C, Spalletta G (2010) Updated meta-analyses reveal thalamus volume reduction in patients with first episode and chronic schizophrenia. Schizophr Res 123:1–14CrossRefPubMed
62.
Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE (2003) Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci 1003:75–93CrossRefPubMed
63.
Ferrarelli F, Tononi G (2011) The thalamic reticular nucleus and schizophrenia. Schizophr Bull 37:306–315CrossRefPubMed
64.
Oke AF, Adams RN (1987) Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophr Bull 13:589–604CrossRefPubMed
65.
Oke AF, Putz C, Adams RN, Bird ED (1992) Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects. Psychiatry Res 45:203–208CrossRefPubMed
66.
Simon H, Le MM, Galey D, Cardo B (1976) Silver impregnation of dopaminergic systems after radiofrequency and 6-OHDA lesions of the rat ventral brain. Brain Res 115:215–231CrossRefPubMed
67.
Young KA, Randall PK, Wilcox RE (1995) Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents. Neuroreport 6:2495–2499CrossRefPubMed
68.
Simpson EH, Winiger V, Biezonski DK, Haq I, Kandel ER, Kellendonk C (2014) Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition. Biol Psychiatry 76:823–831CrossRefPubMed
69.
Clinton SM, Haroutunian V, Davis KL, Meador-Woodruff JH (2003) Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatry 160:1100–1109CrossRefPubMed
70.
Clinton SM, Haroutunian V, Meador-Woodruff JH (2006) Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J Neurochem 98:1114–1125CrossRefPubMed
71.
Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson R-M, Hefner K, Sprengel R, Celikel T, Daws LC, Holmes A (2014) Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors. Mol Psychiatry 13:631–640CrossRef
72.
Inta D, Miriam A, Vogt MA, Elkin H, Weber T, Juan M, Lima-Ojeda JM, Schneider M, Luoni A, Riva MA, Gertz K, Hellmann-Regen J, Kronenberg G, Meyer-Lindenberg A, Sprengel R, Gass P (2014) Phenotype of mice with inducible ablation of GluA1 AMPA receptors during late adolescence: relevance for mental disorders. Hippocampus 24:424–435CrossRefPubMed
73.
Wolf R, Dobrowolny H, Matzke K, Paelchen K, Bogerts B, Schwegler H (2006) Prepulse inhibition is different in two inbred mouse strains (CPB-K and BALB/cJ) with different hippocampal NMDA receptor densities. Behav Brain Res 166:78–84CrossRefPubMed
74.
DiChiara G, Morelli M, Porceddu ML, Gessa GL (1979) Role of thalamic gamma-aminobutyrate in motor functions: catalepsy and ipsiversive turning after intrathalamic muscimol. Neuroscience 4:1453–1465CrossRef
75.
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140–144CrossRef
76.
van Rossum JM (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 160:492–494PubMed
77.
Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998–1007CrossRefPubMed
78.
Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523–533CrossRefPubMed
79.
Tamminga C (1999) Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 37:12–15
80.
Carlsson A, Waters N, Carlsson ML (2000) Network interactions in schizophrenia—therapeutic implications. Brain Res Rev 31:342–349CrossRefPubMed
81.
Benes FM (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev 31:251–269CrossRefPubMed
82.
Lewis DA (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction inschizophrenia. Brain Res Rev 31:270–276CrossRefPubMed
83.
Sharp FR, Tomitaka M, Bernaudin M, Tomitaka S (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci 24:330–334CrossRefPubMed
Metadata
Title
Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat
Authors
Rainer Wolf
Henrik Dobrowolny
Sven Nullmeier
Bernhard Bogerts
Herbert Schwegler
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 5/2018
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-017-0781-2

Other articles of this Issue 5/2018

European Archives of Psychiatry and Clinical Neuroscience 5/2018 Go to the issue

Original Paper

Planning functioning and impulsiveness in obsessive–compulsive disorder

Original Paper

Articulation and testing of a personality-centred model of psychopathology: evidence from a longitudinal community study over 30 years

Original Paper

No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study

Editorial

Biomarkers for Alzheimer’s disease: from pathogenesis to drug development

Original Paper

Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer’s disease patients

Original Paper

Increased quinolinic acid in peripheral mononuclear cells in Alzheimer’s dementia